nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezetimibe—UGT2B7—Epirubicin—sarcoma	0.0874	0.111	CbGbCtD
Ezetimibe—ABCC3—Vincristine—sarcoma	0.086	0.109	CbGbCtD
Ezetimibe—ABCC3—Etoposide—sarcoma	0.0788	0.0997	CbGbCtD
Ezetimibe—UGT1A1—Etoposide—sarcoma	0.0588	0.0745	CbGbCtD
Ezetimibe—ABCG2—Dactinomycin—sarcoma	0.0574	0.0726	CbGbCtD
Ezetimibe—ABCC3—Doxorubicin—sarcoma	0.0537	0.068	CbGbCtD
Ezetimibe—ABCG2—Mitoxantrone—sarcoma	0.0513	0.065	CbGbCtD
Ezetimibe—ABCC2—Vincristine—sarcoma	0.0391	0.0494	CbGbCtD
Ezetimibe—ABCC2—Etoposide—sarcoma	0.0358	0.0453	CbGbCtD
Ezetimibe—ABCG2—Vincristine—sarcoma	0.0353	0.0447	CbGbCtD
Ezetimibe—ABCG2—Etoposide—sarcoma	0.0324	0.041	CbGbCtD
Ezetimibe—CYP3A4—Thiotepa—sarcoma	0.0258	0.0326	CbGbCtD
Ezetimibe—ABCC2—Doxorubicin—sarcoma	0.0244	0.0309	CbGbCtD
Ezetimibe—ABCG2—Doxorubicin—sarcoma	0.0221	0.0279	CbGbCtD
Ezetimibe—ABCB1—Dactinomycin—sarcoma	0.0207	0.0262	CbGbCtD
Ezetimibe—ABCB1—Mitoxantrone—sarcoma	0.0185	0.0234	CbGbCtD
Ezetimibe—ABCB1—Vincristine—sarcoma	0.0127	0.0161	CbGbCtD
Ezetimibe—ABCB1—Etoposide—sarcoma	0.0117	0.0148	CbGbCtD
Ezetimibe—CYP3A4—Mitoxantrone—sarcoma	0.0111	0.014	CbGbCtD
Ezetimibe—ABCB1—Doxorubicin—sarcoma	0.00796	0.0101	CbGbCtD
Ezetimibe—CYP3A4—Vincristine—sarcoma	0.00763	0.00966	CbGbCtD
Ezetimibe—CYP3A4—Etoposide—sarcoma	0.00699	0.00885	CbGbCtD
Ezetimibe—ABCG5—hematopoietic system—sarcoma	0.00604	0.0671	CbGeAlD
Ezetimibe—NPC1L1—hematopoietic system—sarcoma	0.00568	0.063	CbGeAlD
Ezetimibe—ABCG8—hematopoietic system—sarcoma	0.00538	0.0598	CbGeAlD
Ezetimibe—CYP3A4—Doxorubicin—sarcoma	0.00477	0.00604	CbGbCtD
Ezetimibe—UGT2B15—mammary gland—sarcoma	0.00371	0.0412	CbGeAlD
Ezetimibe—ABCG5—liver—sarcoma	0.00313	0.0347	CbGeAlD
Ezetimibe—NPC1L1—testis—sarcoma	0.00311	0.0346	CbGeAlD
Ezetimibe—ANPEP—mammary gland—sarcoma	0.00305	0.0339	CbGeAlD
Ezetimibe—NPC1L1—liver—sarcoma	0.00294	0.0327	CbGeAlD
Ezetimibe—ABCG8—liver—sarcoma	0.00279	0.031	CbGeAlD
Ezetimibe—SOAT1—myometrium—sarcoma	0.00227	0.0251	CbGeAlD
Ezetimibe—ANPEP—myometrium—sarcoma	0.00217	0.0241	CbGeAlD
Ezetimibe—ANPEP—embryo—sarcoma	0.00208	0.0231	CbGeAlD
Ezetimibe—SOAT1—seminal vesicle—sarcoma	0.00205	0.0227	CbGeAlD
Ezetimibe—ANPEP—seminal vesicle—sarcoma	0.00196	0.0217	CbGeAlD
Ezetimibe—SOAT1—hematopoietic system—sarcoma	0.00195	0.0216	CbGeAlD
Ezetimibe—SOAT1—connective tissue—sarcoma	0.00187	0.0208	CbGeAlD
Ezetimibe—ANPEP—hematopoietic system—sarcoma	0.00186	0.0207	CbGeAlD
Ezetimibe—ANPEP—connective tissue—sarcoma	0.00179	0.0199	CbGeAlD
Ezetimibe—SOAT1—smooth muscle tissue—sarcoma	0.00171	0.019	CbGeAlD
Ezetimibe—ANPEP—smooth muscle tissue—sarcoma	0.00164	0.0182	CbGeAlD
Ezetimibe—ANPEP—skin of body—sarcoma	0.00162	0.018	CbGeAlD
Ezetimibe—SLCO1B1—mammary gland—sarcoma	0.0016	0.0178	CbGeAlD
Ezetimibe—ANPEP—uterus—sarcoma	0.00141	0.0156	CbGeAlD
Ezetimibe—ANPEP—lymphoid tissue—sarcoma	0.00131	0.0145	CbGeAlD
Ezetimibe—SOAT1—tendon—sarcoma	0.00129	0.0143	CbGeAlD
Ezetimibe—SOAT1—bone marrow—sarcoma	0.00125	0.0138	CbGeAlD
Ezetimibe—UGT1A3—liver—sarcoma	0.00125	0.0138	CbGeAlD
Ezetimibe—ANPEP—tendon—sarcoma	0.00123	0.0137	CbGeAlD
Ezetimibe—ANPEP—bone marrow—sarcoma	0.00119	0.0132	CbGeAlD
Ezetimibe—UGT1A1—hematopoietic system—sarcoma	0.00117	0.013	CbGeAlD
Ezetimibe—UGT2B15—liver—sarcoma	0.00117	0.013	CbGeAlD
Ezetimibe—SOAT1—testis—sarcoma	0.00107	0.0118	CbGeAlD
Ezetimibe—ANPEP—testis—sarcoma	0.00102	0.0113	CbGeAlD
Ezetimibe—SOAT1—liver—sarcoma	0.00101	0.0112	CbGeAlD
Ezetimibe—SLCO1B1—hematopoietic system—sarcoma	0.000977	0.0108	CbGeAlD
Ezetimibe—ANPEP—liver—sarcoma	0.000964	0.0107	CbGeAlD
Ezetimibe—ABCC3—hematopoietic system—sarcoma	0.000927	0.0103	CbGeAlD
Ezetimibe—SOAT1—lymph node—sarcoma	0.000773	0.00858	CbGeAlD
Ezetimibe—UGT2B7—testis—sarcoma	0.000757	0.0084	CbGeAlD
Ezetimibe—ANPEP—lymph node—sarcoma	0.000739	0.0082	CbGeAlD
Ezetimibe—UGT2B7—liver—sarcoma	0.000716	0.00794	CbGeAlD
Ezetimibe—ABCG2—myometrium—sarcoma	0.000629	0.00699	CbGeAlD
Ezetimibe—UGT1A1—liver—sarcoma	0.000609	0.00675	CbGeAlD
Ezetimibe—ABCG2—seminal vesicle—sarcoma	0.000569	0.00631	CbGeAlD
Ezetimibe—ABCC3—testis—sarcoma	0.000508	0.00564	CbGeAlD
Ezetimibe—SLCO1B1—liver—sarcoma	0.000506	0.00562	CbGeAlD
Ezetimibe—ABCC2—tendon—sarcoma	0.00049	0.00544	CbGeAlD
Ezetimibe—ABCC3—liver—sarcoma	0.00048	0.00533	CbGeAlD
Ezetimibe—ABCG2—uterus—sarcoma	0.000408	0.00453	CbGeAlD
Ezetimibe—ABCC2—testis—sarcoma	0.000406	0.00451	CbGeAlD
Ezetimibe—ABCC2—liver—sarcoma	0.000384	0.00426	CbGeAlD
Ezetimibe—CYP3A4—hematopoietic system—sarcoma	0.000376	0.00418	CbGeAlD
Ezetimibe—ABCC3—lymph node—sarcoma	0.000368	0.00409	CbGeAlD
Ezetimibe—ABCG2—bone marrow—sarcoma	0.000346	0.00384	CbGeAlD
Ezetimibe—ABCB1—myometrium—sarcoma	0.00031	0.00344	CbGeAlD
Ezetimibe—ABCB1—embryo—sarcoma	0.000298	0.00331	CbGeAlD
Ezetimibe—ABCG2—testis—sarcoma	0.000296	0.00329	CbGeAlD
Ezetimibe—ABCC2—lymph node—sarcoma	0.000294	0.00327	CbGeAlD
Ezetimibe—Menopausal symptoms—Doxorubicin—sarcoma	0.000281	0.00234	CcSEcCtD
Ezetimibe—ABCB1—seminal vesicle—sarcoma	0.00028	0.00311	CbGeAlD
Ezetimibe—Insomnia—Vincristine—sarcoma	0.00028	0.00234	CcSEcCtD
Ezetimibe—ABCG2—liver—sarcoma	0.00028	0.00311	CbGeAlD
Ezetimibe—Paraesthesia—Vincristine—sarcoma	0.000278	0.00232	CcSEcCtD
Ezetimibe—Urticaria—Thiotepa—sarcoma	0.000277	0.00232	CcSEcCtD
Ezetimibe—Malaise—Etoposide—sarcoma	0.000277	0.00231	CcSEcCtD
Ezetimibe—Body temperature increased—Thiotepa—sarcoma	0.000276	0.0023	CcSEcCtD
Ezetimibe—Abdominal pain—Thiotepa—sarcoma	0.000276	0.0023	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000275	0.00229	CcSEcCtD
Ezetimibe—Abdominal pain—Dactinomycin—sarcoma	0.000274	0.00229	CcSEcCtD
Ezetimibe—Body temperature increased—Dactinomycin—sarcoma	0.000274	0.00229	CcSEcCtD
Ezetimibe—Paraesthesia—Mitoxantrone—sarcoma	0.000271	0.00226	CcSEcCtD
Ezetimibe—Decreased appetite—Vincristine—sarcoma	0.000269	0.00225	CcSEcCtD
Ezetimibe—Dyspnoea—Mitoxantrone—sarcoma	0.000269	0.00224	CcSEcCtD
Ezetimibe—Cough—Etoposide—sarcoma	0.000268	0.00224	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Vincristine—sarcoma	0.000267	0.00223	CcSEcCtD
Ezetimibe—Fatigue—Vincristine—sarcoma	0.000267	0.00223	CcSEcCtD
Ezetimibe—ABCB1—hematopoietic system—sarcoma	0.000266	0.00296	CbGeAlD
Ezetimibe—Dyspepsia—Mitoxantrone—sarcoma	0.000266	0.00222	CcSEcCtD
Ezetimibe—Hypertension—Etoposide—sarcoma	0.000265	0.00221	CcSEcCtD
Ezetimibe—Pain—Vincristine—sarcoma	0.000265	0.00221	CcSEcCtD
Ezetimibe—Constipation—Vincristine—sarcoma	0.000265	0.00221	CcSEcCtD
Ezetimibe—Pain in extremity—Doxorubicin—sarcoma	0.000265	0.00221	CcSEcCtD
Ezetimibe—Liver function test abnormal—Epirubicin—sarcoma	0.000264	0.0022	CcSEcCtD
Ezetimibe—Decreased appetite—Mitoxantrone—sarcoma	0.000262	0.00219	CcSEcCtD
Ezetimibe—Chest pain—Etoposide—sarcoma	0.000262	0.00218	CcSEcCtD
Ezetimibe—Fatigue—Mitoxantrone—sarcoma	0.00026	0.00217	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00026	0.00217	CcSEcCtD
Ezetimibe—Discomfort—Etoposide—sarcoma	0.000259	0.00216	CcSEcCtD
Ezetimibe—Breast disorder—Epirubicin—sarcoma	0.000259	0.00216	CcSEcCtD
Ezetimibe—Constipation—Mitoxantrone—sarcoma	0.000258	0.00215	CcSEcCtD
Ezetimibe—Pain—Mitoxantrone—sarcoma	0.000258	0.00215	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000258	0.00215	CcSEcCtD
Ezetimibe—Hypersensitivity—Thiotepa—sarcoma	0.000257	0.00215	CcSEcCtD
Ezetimibe—Nasopharyngitis—Epirubicin—sarcoma	0.000256	0.00214	CcSEcCtD
Ezetimibe—Hypersensitivity—Dactinomycin—sarcoma	0.000255	0.00213	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Vincristine—sarcoma	0.000253	0.00211	CcSEcCtD
Ezetimibe—Gastritis—Epirubicin—sarcoma	0.000253	0.00211	CcSEcCtD
Ezetimibe—Confusional state—Etoposide—sarcoma	0.000253	0.00211	CcSEcCtD
Ezetimibe—Muscular weakness—Epirubicin—sarcoma	0.000252	0.00211	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000252	0.00211	CcSEcCtD
Ezetimibe—Anaphylactic shock—Etoposide—sarcoma	0.000251	0.00209	CcSEcCtD
Ezetimibe—Asthenia—Thiotepa—sarcoma	0.000251	0.00209	CcSEcCtD
Ezetimibe—Infection—Etoposide—sarcoma	0.000249	0.00208	CcSEcCtD
Ezetimibe—Asthenia—Dactinomycin—sarcoma	0.000249	0.00208	CcSEcCtD
Ezetimibe—Feeling abnormal—Mitoxantrone—sarcoma	0.000249	0.00207	CcSEcCtD
Ezetimibe—Influenza—Epirubicin—sarcoma	0.000247	0.00206	CcSEcCtD
Ezetimibe—Pruritus—Thiotepa—sarcoma	0.000247	0.00206	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000247	0.00206	CcSEcCtD
Ezetimibe—Thrombocytopenia—Etoposide—sarcoma	0.000246	0.00205	CcSEcCtD
Ezetimibe—Eosinophilia—Epirubicin—sarcoma	0.000245	0.00204	CcSEcCtD
Ezetimibe—Abdominal pain—Vincristine—sarcoma	0.000245	0.00204	CcSEcCtD
Ezetimibe—Body temperature increased—Vincristine—sarcoma	0.000245	0.00204	CcSEcCtD
Ezetimibe—Liver function test abnormal—Doxorubicin—sarcoma	0.000244	0.00204	CcSEcCtD
Ezetimibe—Skin disorder—Etoposide—sarcoma	0.000244	0.00203	CcSEcCtD
Ezetimibe—Pancreatitis—Epirubicin—sarcoma	0.000242	0.00202	CcSEcCtD
Ezetimibe—Urticaria—Mitoxantrone—sarcoma	0.00024	0.002	CcSEcCtD
Ezetimibe—Breast disorder—Doxorubicin—sarcoma	0.000239	0.002	CcSEcCtD
Ezetimibe—Diarrhoea—Thiotepa—sarcoma	0.000239	0.00199	CcSEcCtD
Ezetimibe—Abdominal pain—Mitoxantrone—sarcoma	0.000238	0.00199	CcSEcCtD
Ezetimibe—Body temperature increased—Mitoxantrone—sarcoma	0.000238	0.00199	CcSEcCtD
Ezetimibe—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000238	0.00199	CcSEcCtD
Ezetimibe—Diarrhoea—Dactinomycin—sarcoma	0.000237	0.00198	CcSEcCtD
Ezetimibe—Nasopharyngitis—Doxorubicin—sarcoma	0.000237	0.00198	CcSEcCtD
Ezetimibe—Gastritis—Doxorubicin—sarcoma	0.000234	0.00196	CcSEcCtD
Ezetimibe—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000234	0.00195	CcSEcCtD
Ezetimibe—Muscular weakness—Doxorubicin—sarcoma	0.000234	0.00195	CcSEcCtD
Ezetimibe—Dizziness—Thiotepa—sarcoma	0.000231	0.00193	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Epirubicin—sarcoma	0.00023	0.00192	CcSEcCtD
Ezetimibe—Influenza—Doxorubicin—sarcoma	0.000229	0.00191	CcSEcCtD
Ezetimibe—Hypersensitivity—Vincristine—sarcoma	0.000228	0.0019	CcSEcCtD
Ezetimibe—Eosinophilia—Doxorubicin—sarcoma	0.000227	0.00189	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Epirubicin—sarcoma	0.000226	0.00188	CcSEcCtD
Ezetimibe—Paraesthesia—Etoposide—sarcoma	0.000225	0.00188	CcSEcCtD
Ezetimibe—Pancreatitis—Doxorubicin—sarcoma	0.000224	0.00187	CcSEcCtD
Ezetimibe—Dyspnoea—Etoposide—sarcoma	0.000224	0.00187	CcSEcCtD
Ezetimibe—Hypersensitivity—Mitoxantrone—sarcoma	0.000222	0.00185	CcSEcCtD
Ezetimibe—Asthenia—Vincristine—sarcoma	0.000222	0.00185	CcSEcCtD
Ezetimibe—Vomiting—Thiotepa—sarcoma	0.000222	0.00185	CcSEcCtD
Ezetimibe—Infestation NOS—Epirubicin—sarcoma	0.000221	0.00184	CcSEcCtD
Ezetimibe—Infestation—Epirubicin—sarcoma	0.000221	0.00184	CcSEcCtD
Ezetimibe—Vomiting—Dactinomycin—sarcoma	0.00022	0.00184	CcSEcCtD
Ezetimibe—Rash—Thiotepa—sarcoma	0.00022	0.00184	CcSEcCtD
Ezetimibe—Dermatitis—Thiotepa—sarcoma	0.00022	0.00184	CcSEcCtD
Ezetimibe—Headache—Thiotepa—sarcoma	0.000219	0.00183	CcSEcCtD
Ezetimibe—Rash—Dactinomycin—sarcoma	0.000219	0.00182	CcSEcCtD
Ezetimibe—Decreased appetite—Etoposide—sarcoma	0.000218	0.00182	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Etoposide—sarcoma	0.000217	0.00181	CcSEcCtD
Ezetimibe—Asthenia—Mitoxantrone—sarcoma	0.000216	0.00181	CcSEcCtD
Ezetimibe—Fatigue—Etoposide—sarcoma	0.000216	0.0018	CcSEcCtD
Ezetimibe—Neuropathy peripheral—Epirubicin—sarcoma	0.000216	0.0018	CcSEcCtD
Ezetimibe—Jaundice—Epirubicin—sarcoma	0.000215	0.00179	CcSEcCtD
Ezetimibe—ABCG2—lymph node—sarcoma	0.000215	0.00238	CbGeAlD
Ezetimibe—Constipation—Etoposide—sarcoma	0.000215	0.00179	CcSEcCtD
Ezetimibe—Pain—Etoposide—sarcoma	0.000215	0.00179	CcSEcCtD
Ezetimibe—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000213	0.00177	CcSEcCtD
Ezetimibe—Diarrhoea—Vincristine—sarcoma	0.000212	0.00177	CcSEcCtD
Ezetimibe—Photosensitivity reaction—Doxorubicin—sarcoma	0.000209	0.00174	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Epirubicin—sarcoma	0.000209	0.00174	CcSEcCtD
Ezetimibe—Nausea—Thiotepa—sarcoma	0.000207	0.00173	CcSEcCtD
Ezetimibe—Sinusitis—Epirubicin—sarcoma	0.000207	0.00173	CcSEcCtD
Ezetimibe—Feeling abnormal—Etoposide—sarcoma	0.000207	0.00173	CcSEcCtD
Ezetimibe—Diarrhoea—Mitoxantrone—sarcoma	0.000206	0.00172	CcSEcCtD
Ezetimibe—Nausea—Dactinomycin—sarcoma	0.000206	0.00172	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Etoposide—sarcoma	0.000205	0.00171	CcSEcCtD
Ezetimibe—Dizziness—Vincristine—sarcoma	0.000205	0.00171	CcSEcCtD
Ezetimibe—Infestation NOS—Doxorubicin—sarcoma	0.000204	0.0017	CcSEcCtD
Ezetimibe—Infestation—Doxorubicin—sarcoma	0.000204	0.0017	CcSEcCtD
Ezetimibe—ABCB1—uterus—sarcoma	0.000201	0.00223	CbGeAlD
Ezetimibe—Neuropathy peripheral—Doxorubicin—sarcoma	0.0002	0.00167	CcSEcCtD
Ezetimibe—Urticaria—Etoposide—sarcoma	0.000199	0.00166	CcSEcCtD
Ezetimibe—Jaundice—Doxorubicin—sarcoma	0.000199	0.00166	CcSEcCtD
Ezetimibe—Abdominal pain—Etoposide—sarcoma	0.000198	0.00165	CcSEcCtD
Ezetimibe—Body temperature increased—Etoposide—sarcoma	0.000198	0.00165	CcSEcCtD
Ezetimibe—Hepatitis—Epirubicin—sarcoma	0.000198	0.00165	CcSEcCtD
Ezetimibe—Vomiting—Vincristine—sarcoma	0.000197	0.00164	CcSEcCtD
Ezetimibe—Pharyngitis—Epirubicin—sarcoma	0.000196	0.00164	CcSEcCtD
Ezetimibe—Rash—Vincristine—sarcoma	0.000195	0.00163	CcSEcCtD
Ezetimibe—Dermatitis—Vincristine—sarcoma	0.000195	0.00163	CcSEcCtD
Ezetimibe—CYP3A4—liver—sarcoma	0.000195	0.00216	CbGeAlD
Ezetimibe—Oedema peripheral—Epirubicin—sarcoma	0.000195	0.00163	CcSEcCtD
Ezetimibe—Connective tissue disorder—Epirubicin—sarcoma	0.000195	0.00162	CcSEcCtD
Ezetimibe—Headache—Vincristine—sarcoma	0.000194	0.00162	CcSEcCtD
Ezetimibe—Hepatobiliary disease—Doxorubicin—sarcoma	0.000193	0.00161	CcSEcCtD
Ezetimibe—Vomiting—Mitoxantrone—sarcoma	0.000192	0.0016	CcSEcCtD
Ezetimibe—Sinusitis—Doxorubicin—sarcoma	0.000191	0.0016	CcSEcCtD
Ezetimibe—Rash—Mitoxantrone—sarcoma	0.00019	0.00159	CcSEcCtD
Ezetimibe—Dermatitis—Mitoxantrone—sarcoma	0.00019	0.00159	CcSEcCtD
Ezetimibe—Headache—Mitoxantrone—sarcoma	0.000189	0.00158	CcSEcCtD
Ezetimibe—ABCB1—lymphoid tissue—sarcoma	0.000188	0.00208	CbGeAlD
Ezetimibe—Erythema multiforme—Epirubicin—sarcoma	0.000187	0.00156	CcSEcCtD
Ezetimibe—Hypersensitivity—Etoposide—sarcoma	0.000185	0.00154	CcSEcCtD
Ezetimibe—Nausea—Vincristine—sarcoma	0.000184	0.00154	CcSEcCtD
Ezetimibe—Flushing—Epirubicin—sarcoma	0.000184	0.00153	CcSEcCtD
Ezetimibe—Hepatitis—Doxorubicin—sarcoma	0.000183	0.00153	CcSEcCtD
Ezetimibe—Pharyngitis—Doxorubicin—sarcoma	0.000182	0.00152	CcSEcCtD
Ezetimibe—Oedema peripheral—Doxorubicin—sarcoma	0.00018	0.00151	CcSEcCtD
Ezetimibe—Asthenia—Etoposide—sarcoma	0.00018	0.0015	CcSEcCtD
Ezetimibe—Connective tissue disorder—Doxorubicin—sarcoma	0.00018	0.0015	CcSEcCtD
Ezetimibe—Angiopathy—Epirubicin—sarcoma	0.00018	0.0015	CcSEcCtD
Ezetimibe—Nausea—Mitoxantrone—sarcoma	0.000179	0.00149	CcSEcCtD
Ezetimibe—Immune system disorder—Epirubicin—sarcoma	0.000179	0.00149	CcSEcCtD
Ezetimibe—Mediastinal disorder—Epirubicin—sarcoma	0.000178	0.00149	CcSEcCtD
Ezetimibe—Pruritus—Etoposide—sarcoma	0.000178	0.00148	CcSEcCtD
Ezetimibe—Alopecia—Epirubicin—sarcoma	0.000175	0.00146	CcSEcCtD
Ezetimibe—Mental disorder—Epirubicin—sarcoma	0.000173	0.00145	CcSEcCtD
Ezetimibe—Erythema multiforme—Doxorubicin—sarcoma	0.000173	0.00145	CcSEcCtD
Ezetimibe—Malnutrition—Epirubicin—sarcoma	0.000172	0.00144	CcSEcCtD
Ezetimibe—Erythema—Epirubicin—sarcoma	0.000172	0.00144	CcSEcCtD
Ezetimibe—Diarrhoea—Etoposide—sarcoma	0.000172	0.00143	CcSEcCtD
Ezetimibe—ABCB1—bone marrow—sarcoma	0.000171	0.0019	CbGeAlD
Ezetimibe—Flushing—Doxorubicin—sarcoma	0.00017	0.00142	CcSEcCtD
Ezetimibe—Flatulence—Epirubicin—sarcoma	0.00017	0.00142	CcSEcCtD
Ezetimibe—Back pain—Epirubicin—sarcoma	0.000167	0.00139	CcSEcCtD
Ezetimibe—Angiopathy—Doxorubicin—sarcoma	0.000166	0.00139	CcSEcCtD
Ezetimibe—Dizziness—Etoposide—sarcoma	0.000166	0.00138	CcSEcCtD
Ezetimibe—Muscle spasms—Epirubicin—sarcoma	0.000166	0.00138	CcSEcCtD
Ezetimibe—Immune system disorder—Doxorubicin—sarcoma	0.000165	0.00138	CcSEcCtD
Ezetimibe—Mediastinal disorder—Doxorubicin—sarcoma	0.000165	0.00138	CcSEcCtD
Ezetimibe—Alopecia—Doxorubicin—sarcoma	0.000162	0.00135	CcSEcCtD
Ezetimibe—Mental disorder—Doxorubicin—sarcoma	0.00016	0.00134	CcSEcCtD
Ezetimibe—Ill-defined disorder—Epirubicin—sarcoma	0.00016	0.00133	CcSEcCtD
Ezetimibe—Vomiting—Etoposide—sarcoma	0.00016	0.00133	CcSEcCtD
Ezetimibe—Malnutrition—Doxorubicin—sarcoma	0.000159	0.00133	CcSEcCtD
Ezetimibe—Erythema—Doxorubicin—sarcoma	0.000159	0.00133	CcSEcCtD
Ezetimibe—Anaemia—Epirubicin—sarcoma	0.000159	0.00133	CcSEcCtD
Ezetimibe—Rash—Etoposide—sarcoma	0.000158	0.00132	CcSEcCtD
Ezetimibe—Dermatitis—Etoposide—sarcoma	0.000158	0.00132	CcSEcCtD
Ezetimibe—Headache—Etoposide—sarcoma	0.000157	0.00131	CcSEcCtD
Ezetimibe—Flatulence—Doxorubicin—sarcoma	0.000157	0.00131	CcSEcCtD
Ezetimibe—Malaise—Epirubicin—sarcoma	0.000155	0.0013	CcSEcCtD
Ezetimibe—Back pain—Doxorubicin—sarcoma	0.000154	0.00129	CcSEcCtD
Ezetimibe—Muscle spasms—Doxorubicin—sarcoma	0.000153	0.00128	CcSEcCtD
Ezetimibe—Palpitations—Epirubicin—sarcoma	0.000152	0.00127	CcSEcCtD
Ezetimibe—Cough—Epirubicin—sarcoma	0.00015	0.00125	CcSEcCtD
Ezetimibe—Nausea—Etoposide—sarcoma	0.000149	0.00124	CcSEcCtD
Ezetimibe—Hypertension—Epirubicin—sarcoma	0.000149	0.00124	CcSEcCtD
Ezetimibe—Ill-defined disorder—Doxorubicin—sarcoma	0.000148	0.00123	CcSEcCtD
Ezetimibe—Anaemia—Doxorubicin—sarcoma	0.000147	0.00123	CcSEcCtD
Ezetimibe—Myalgia—Epirubicin—sarcoma	0.000147	0.00122	CcSEcCtD
Ezetimibe—Chest pain—Epirubicin—sarcoma	0.000147	0.00122	CcSEcCtD
Ezetimibe—Arthralgia—Epirubicin—sarcoma	0.000147	0.00122	CcSEcCtD
Ezetimibe—ABCB1—testis—sarcoma	0.000146	0.00162	CbGeAlD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000146	0.00122	CcSEcCtD
Ezetimibe—Discomfort—Epirubicin—sarcoma	0.000145	0.00121	CcSEcCtD
Ezetimibe—Malaise—Doxorubicin—sarcoma	0.000144	0.0012	CcSEcCtD
Ezetimibe—Dry mouth—Epirubicin—sarcoma	0.000143	0.0012	CcSEcCtD
Ezetimibe—Confusional state—Epirubicin—sarcoma	0.000142	0.00118	CcSEcCtD
Ezetimibe—Palpitations—Doxorubicin—sarcoma	0.000141	0.00118	CcSEcCtD
Ezetimibe—Anaphylactic shock—Epirubicin—sarcoma	0.000141	0.00117	CcSEcCtD
Ezetimibe—Infection—Epirubicin—sarcoma	0.00014	0.00117	CcSEcCtD
Ezetimibe—Cough—Doxorubicin—sarcoma	0.000139	0.00116	CcSEcCtD
Ezetimibe—ABCB1—liver—sarcoma	0.000138	0.00153	CbGeAlD
Ezetimibe—Nervous system disorder—Epirubicin—sarcoma	0.000138	0.00115	CcSEcCtD
Ezetimibe—Thrombocytopenia—Epirubicin—sarcoma	0.000138	0.00115	CcSEcCtD
Ezetimibe—Hypertension—Doxorubicin—sarcoma	0.000138	0.00115	CcSEcCtD
Ezetimibe—Skin disorder—Epirubicin—sarcoma	0.000137	0.00114	CcSEcCtD
Ezetimibe—Arthralgia—Doxorubicin—sarcoma	0.000136	0.00113	CcSEcCtD
Ezetimibe—Chest pain—Doxorubicin—sarcoma	0.000136	0.00113	CcSEcCtD
Ezetimibe—Myalgia—Doxorubicin—sarcoma	0.000136	0.00113	CcSEcCtD
Ezetimibe—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000135	0.00112	CcSEcCtD
Ezetimibe—Discomfort—Doxorubicin—sarcoma	0.000134	0.00112	CcSEcCtD
Ezetimibe—Dry mouth—Doxorubicin—sarcoma	0.000133	0.00111	CcSEcCtD
Ezetimibe—Confusional state—Doxorubicin—sarcoma	0.000131	0.00109	CcSEcCtD
Ezetimibe—Anaphylactic shock—Doxorubicin—sarcoma	0.00013	0.00109	CcSEcCtD
Ezetimibe—Infection—Doxorubicin—sarcoma	0.000129	0.00108	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000128	0.00107	CcSEcCtD
Ezetimibe—Nervous system disorder—Doxorubicin—sarcoma	0.000128	0.00106	CcSEcCtD
Ezetimibe—Thrombocytopenia—Doxorubicin—sarcoma	0.000127	0.00106	CcSEcCtD
Ezetimibe—Insomnia—Epirubicin—sarcoma	0.000127	0.00106	CcSEcCtD
Ezetimibe—Skin disorder—Doxorubicin—sarcoma	0.000126	0.00105	CcSEcCtD
Ezetimibe—Paraesthesia—Epirubicin—sarcoma	0.000126	0.00105	CcSEcCtD
Ezetimibe—Dyspnoea—Epirubicin—sarcoma	0.000125	0.00105	CcSEcCtD
Ezetimibe—Dyspepsia—Epirubicin—sarcoma	0.000124	0.00103	CcSEcCtD
Ezetimibe—Decreased appetite—Epirubicin—sarcoma	0.000122	0.00102	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Epirubicin—sarcoma	0.000121	0.00101	CcSEcCtD
Ezetimibe—Fatigue—Epirubicin—sarcoma	0.000121	0.00101	CcSEcCtD
Ezetimibe—Pain—Epirubicin—sarcoma	0.00012	0.001	CcSEcCtD
Ezetimibe—Constipation—Epirubicin—sarcoma	0.00012	0.001	CcSEcCtD
Ezetimibe—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000119	0.000989	CcSEcCtD
Ezetimibe—Insomnia—Doxorubicin—sarcoma	0.000118	0.000982	CcSEcCtD
Ezetimibe—Paraesthesia—Doxorubicin—sarcoma	0.000117	0.000975	CcSEcCtD
Ezetimibe—Dyspnoea—Doxorubicin—sarcoma	0.000116	0.000968	CcSEcCtD
Ezetimibe—Feeling abnormal—Epirubicin—sarcoma	0.000116	0.000967	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Epirubicin—sarcoma	0.000115	0.00096	CcSEcCtD
Ezetimibe—Dyspepsia—Doxorubicin—sarcoma	0.000115	0.000956	CcSEcCtD
Ezetimibe—Decreased appetite—Doxorubicin—sarcoma	0.000113	0.000944	CcSEcCtD
Ezetimibe—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000112	0.000937	CcSEcCtD
Ezetimibe—Fatigue—Doxorubicin—sarcoma	0.000112	0.000936	CcSEcCtD
Ezetimibe—Urticaria—Epirubicin—sarcoma	0.000112	0.000932	CcSEcCtD
Ezetimibe—Pain—Doxorubicin—sarcoma	0.000111	0.000929	CcSEcCtD
Ezetimibe—Constipation—Doxorubicin—sarcoma	0.000111	0.000929	CcSEcCtD
Ezetimibe—Body temperature increased—Epirubicin—sarcoma	0.000111	0.000928	CcSEcCtD
Ezetimibe—Abdominal pain—Epirubicin—sarcoma	0.000111	0.000928	CcSEcCtD
Ezetimibe—Feeling abnormal—Doxorubicin—sarcoma	0.000107	0.000895	CcSEcCtD
Ezetimibe—Gastrointestinal pain—Doxorubicin—sarcoma	0.000106	0.000888	CcSEcCtD
Ezetimibe—ABCB1—lymph node—sarcoma	0.000106	0.00117	CbGeAlD
Ezetimibe—Hypersensitivity—Epirubicin—sarcoma	0.000104	0.000865	CcSEcCtD
Ezetimibe—Urticaria—Doxorubicin—sarcoma	0.000103	0.000863	CcSEcCtD
Ezetimibe—Abdominal pain—Doxorubicin—sarcoma	0.000103	0.000858	CcSEcCtD
Ezetimibe—Body temperature increased—Doxorubicin—sarcoma	0.000103	0.000858	CcSEcCtD
Ezetimibe—Asthenia—Epirubicin—sarcoma	0.000101	0.000842	CcSEcCtD
Ezetimibe—Pruritus—Epirubicin—sarcoma	9.95e-05	0.00083	CcSEcCtD
Ezetimibe—Diarrhoea—Epirubicin—sarcoma	9.62e-05	0.000803	CcSEcCtD
Ezetimibe—Hypersensitivity—Doxorubicin—sarcoma	9.59e-05	0.0008	CcSEcCtD
Ezetimibe—Asthenia—Doxorubicin—sarcoma	9.34e-05	0.000779	CcSEcCtD
Ezetimibe—Dizziness—Epirubicin—sarcoma	9.3e-05	0.000776	CcSEcCtD
Ezetimibe—Pruritus—Doxorubicin—sarcoma	9.21e-05	0.000768	CcSEcCtD
Ezetimibe—Vomiting—Epirubicin—sarcoma	8.94e-05	0.000746	CcSEcCtD
Ezetimibe—Diarrhoea—Doxorubicin—sarcoma	8.9e-05	0.000743	CcSEcCtD
Ezetimibe—Rash—Epirubicin—sarcoma	8.87e-05	0.00074	CcSEcCtD
Ezetimibe—Dermatitis—Epirubicin—sarcoma	8.86e-05	0.000739	CcSEcCtD
Ezetimibe—Headache—Epirubicin—sarcoma	8.81e-05	0.000735	CcSEcCtD
Ezetimibe—Dizziness—Doxorubicin—sarcoma	8.6e-05	0.000718	CcSEcCtD
Ezetimibe—Nausea—Epirubicin—sarcoma	8.35e-05	0.000697	CcSEcCtD
Ezetimibe—Vomiting—Doxorubicin—sarcoma	8.27e-05	0.00069	CcSEcCtD
Ezetimibe—Rash—Doxorubicin—sarcoma	8.2e-05	0.000685	CcSEcCtD
Ezetimibe—Dermatitis—Doxorubicin—sarcoma	8.2e-05	0.000684	CcSEcCtD
Ezetimibe—Headache—Doxorubicin—sarcoma	8.15e-05	0.00068	CcSEcCtD
Ezetimibe—Nausea—Doxorubicin—sarcoma	7.73e-05	0.000645	CcSEcCtD
